Somatic NF1 deletions were found in almost all (59/60) of the mammary tumours studied in this mouse model, and upon subsequent examination of TCGA data, it was noted that NF1 is somatically mutated or deleted in 27.7% of human breast cancers [105, 106]. Here, NF1 is linked to breast carcinoma.